The mission of the Cancer Imaging Program, National Cancer Institute, is to promote and support: Cancer-related basic, translational and clinical research in imaging sciences and technology, and integration and application of these imaging discoveries and developments to the understanding of cancer biology and to the clinical management of cancer and cancer risk. more >
Programs & Resources
Program Project (P01) Grant Development Guidance for Investigators Interested in DCTD Research Areas
The goal of this guidance is to help investigators navigate through the P01 (Program Project Grant) pre-application process in the cancer research areas that DCTD supports.
The Cancer Imaging Archive
A large archive of medical images of cancer accessible for public use. Images for imaging-genomics research and the LIDC/IDRI collections are archived here.
Co-Clinical Imaging Research Resources Program (CIRP)
NCI-supported research resource network promoting quantitative imaging therapeutic or prevention co-clinical trials with patients and human-in-mouse models.
Quantitative Imaging for Evaluation of Responses to Cancer Therapies (QIN)
CIP-supported network promoting quantitative imaging methods.
CIP IND Directory
The CIP IND Directory is a centralized resource to facilitate the sharing of IND information
IND Regulatory & Manufacturing Resources
Tracer synthesis resources for Investigational New Drug Applications (IND) imaging agents held by the Cancer Imaging Program, including Production Documents and Investigator’s Brochures.
Cancer Imaging Basics
Cancer may be difficult to detect, but for some types of cancer, the earlier it is detected, the better are the chances of treating it effectively. Imaging techniques — methods of producing pictures of the body — have become an important element of early detection for many cancers.
About the Acting Associate Director
Lalitha K. Shankar, MD, PhD, is at the Cancer Imaging Program at the National Cancer Institute, at the National Institutes of Health in Bethesda, MD. Since joining NCI in 2003, she has served as an Advisor to the Associate Director of the Division of Cancer Treatment and Diagnosis. She is the Chief of the Clinical Trials Branch at the Cancer Imaging Program. Her research interests have been both in the role of functional and molecular imaging in the diagnosis and treatment of cancer, as well as evaluating the performance characteristics of imaging modalities for optimal use in the management of the cancer patient. More…